Key result
Allopurinol reduces myocardial infarct size by ~41 percentage points in a canine ischemia model.
Why the study?
A canine ischemic heart model with coronary retrograde flow diversion was evaluated for its usefulness and to study the effect of allopurinol on myocardial infarction.
Answers are grounded in this paper and cite their sources.
Allopurinol reduced infarct size in this canine model; leaves open whether xanthine oxidase inhibition confers human cardioprotection.
This study was undertaken to evaluate the usefulness of a canine ischemic heart model achieved by coronary retrograde flow (RF) diversion, and to examine the effect of allopurinol on the myocardial infarction. The left anterior descending coronary artery (LAD) was occluded for 90 min followed by 4h reperfusion. Group 1 (n = 9) was a simple LAD occlusion group. In group 2 (n = 8), retrograde flowing blood from the distal of the occluded LAD was simultaneously diverted during LAD occlusion. In group 3 (n = 8), allopurinol was administered 60 min before ischemia with RF diversion followed by its continuous infusion. Infarcted myocardium was determined by triphenyl tetrazolium chloride staining and myocardium at risk by the dye double perfusion technique. RF diversion significantly reduced not only regional myocardial blood flow (RBF) (0.21 +/- 0.05 ml/min/g in group 1 vs 0.05 +/- 0.01 ml/min/g in group 2; p less than 0.05) but also its variance (p less than 0.01). Furthermore, the infarct size (infarct/risk ratio) in the allopurinol treated group was significantly reduced without any significant difference in rate pressure product, risk size or RBF (89.4 +/- 4.0% in group 2 vs 48.9 +/- 4.5% in group 3; p less than 0.01). We conclude that the canine RF diversion model is useful for myocardial infarct study because of the minimizing of the difference of collateral flow, and that canine myocardial xanthine oxidase may produce free radicals which take part in myocardial injury after reperfusion.
No takes yet. Share an insight, caveat, or question.
Motoe et al. (1991) studied Ischemic myocardium (n=25). Allopurinol vs. Coronary retrograde flow diversion alone was evaluated on Infarct size (infarct/risk ratio) (p=<0.01). In a canine ischemic heart model with coronary retrograde flow diversion, allopurinol significantly reduced infarct size compared to control (48.9% vs 89.4%; p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: